Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer (NCT03814629) | Clinical Trial Compass
UnknownEarly Phase 1
Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer
120 participantsStarted 2015-08-01
Plain-language summary
Research purpose To elucidate the effect mechanism and clinical effective of weifuchun in the prevention and treatment of chronic atrophic gastritis and precancerous lesions of gastric cancer. From genes related to cell differentiation, proliferation, apoptosis, tumor invasion and metastasis, genes related to immune inflammation and immune escape and other possible aspects to elucidate the effective and mechanism of weifuchun's treatment on chronic atrophic gastritis, reversing precancerous lesions of gastric cancer.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients with chronic atrophic gastritis and precancerous lesions according to the pathological findings under gastroscope
. Helicobacter pylori(-)
Exclusion criteria
. Patients with Helicobacter pylori positive infection without radical treatment.
. Patients with peptic ulcer, severe dysplasia or suspected malignant transformation.
. Pregnant or lactating women and those who are pregnant and may not have effective contraception.
. Patients with severe heart, lung, gallbladder, kidney, endocrine, hematopoietic system and neuropsychiatric diseases should not be included in this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
histopathology is assessing a change
Timeframe: the patients' were included into the clinical trials and after 24 weeks treatment.
2
gastroscopy is assessing a change
Timeframe: the patients' were included into the clinical trials and after 24 weeks treatment.
3
Clinical symptom score is assessing a change
Timeframe: the patients' were included into the clinical trials and after 24 weeks treatment.